After a patient's death, Austria suspends the use of an AstraZeneca vaccine group

The Federal Security Office “for Health Care (BASG) received two reports of a link to vaccines from the same AstraZenecas vaccine group at the Zwetl” clinic, the ministry said.

A 49-year-old has died as a result of serious coagulating disorders, while a 35-year-old has received pulmonary emboli, but is recovering.

There is actually no evidence of the link to the vaccine”, BASG said.

Austrian media report that both women were nurses working at the clinic in Zwettl.

BASG said blood clots are not among the known side effects of the vaccine. He's doing research on every possible connection.

As a precautionary measure, the remaining stock of vaccines in question will no longer be used for vaccination”, BASG said.

AstraZeneca is said to be in contact with Austrian authorities and is fully supporting the investigation.

AstraZeneca for the Agency The APA has said the vaccine was approved by the European Bars Agency (EMA) and by the World Health Organisation based on the global clinical programme, which participated in over 23 thousand participants.

All of these have concluded that anti-mocation vaccines - CO AstraZeneca's VID is safe and efficient”, said by AstraZeneca.